Avidity Partners Management LP grew its holdings in Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE – Free Report) by 55.2% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 844,500 shares of the biopharmaceutical company’s stock after acquiring an additional 300,500 shares during the period. […]
Avidity Partners Management LP decreased its stake in shares of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Free Report) by 11.4% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 710,000 shares of the biopharmaceutical company’s stock after selling 91,100 shares during the period. Intra-Cellular Therapies accounts for about […]
Insulet Co. (NASDAQ:PODD – Get Free Report) SVP Mark N. Field sold 2,131 shares of Insulet stock in a transaction dated Monday, June 10th. The shares were sold at an average price of $190.43, for a total transaction of $405,806.33. Following the completion of the transaction, the senior vice president now directly owns 14,375 shares […]
Avidity Partners Management LP lowered its stake in shares of Akero Therapeutics, Inc. (NASDAQ:AKRO – Free Report) by 68.2% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 235,000 shares of the company’s stock after selling 504,100 shares during the quarter. Avidity Partners Management LP […]
Avidity Partners Management LP lowered its stake in shares of Akero Therapeutics, Inc. (NASDAQ:AKRO – Free Report) by 68.2% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 235,000 shares of the company’s stock after selling 504,100 shares during the quarter. Avidity Partners Management LP […]